{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:41Z","timestamp":1785542441844,"version":"3.56.0"},"reference-count":23,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Dialysis"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Age is a risk factor for both cancer and end\u2010stage renal disease (ESRD). Newer cancer treatments are allowing patients to live longer with their cancer, the renal toxicity from the cancer itself or from the therapies that was used to treat the malignancy. Consequently, nephrologists will increasingly be asked to evaluate and counsel patients with ESRD and advanced cancer regarding the initiation of dialysis. Data on morbidity, mortality, and quality of life (QOL) outcomes in this population are sparse. Expectations regarding what dialysis can reasonably accomplish in this cohort can be unrealistically high among patients, their family members and the rest of the health care team. This article will discuss some results from the available studies on mortality and QOL outcomes in this cohort and advise the nephrologist about how to approach these challenging discussions.<\/jats:p>","DOI":"10.1111\/sdi.12780","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T07:39:13Z","timestamp":1553067553000},"page":"215-218","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Decision making for the initiation and termination of dialysis in patients with advanced cancer"],"prefix":"10.1111","volume":"32","author":[{"given":"Sheron","family":"Latcha","sequence":"first","affiliation":[{"name":"Renal Division, Department of Medicine Memorial Sloan Kettering Cancer Center New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"key":"e_1_2_3_2_1","unstructured":"USRDS.United States Renal Data System: Chapter 5 Mortality.2017;https:\/\/www.usrds.org\/2017\/download\/v2_c05_Mortality_17.pdf. Accessed March 1 2019 2018."},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04360709"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2013.07.005"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn698"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh637"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2253-13-36"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.05.7869"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2016.0105"},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198212000-00014"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-13-72"},{"key":"e_1_2_3_12_1","unstructured":"FademS.Charlson Comorbidity Scoring System.2008;http:\/\/touchcalc.com\/calculators\/cci_js. Accessed March 1 2019 2018."},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40697-015-0068-3"},{"key":"e_1_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq433"},{"key":"e_1_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05960809"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00590118"},{"key":"e_1_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/089686080502500310"},{"key":"e_1_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7233.469"},{"key":"e_1_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7408.195"},{"key":"e_1_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-12-200106190-00009"},{"key":"e_1_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.09.030"},{"key":"e_1_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1000678"},{"key":"e_1_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.9980"},{"key":"e_1_2_3_24_1","volume-title":"The clinical evaluation of chemotherapeutic agents in cancer","author":"Karnofsky DA BJ","year":"1949"}],"container-title":["Seminars in Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/sdi.12780","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/sdi.12780","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/sdi.12780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T22:01:14Z","timestamp":1694383274000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/sdi.12780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1111\/sdi.12780"],"URL":"https:\/\/doi.org\/10.1111\/sdi.12780","archive":["Portico"],"relation":{},"ISSN":["0894-0959","1525-139X"],"issn-type":[{"value":"0894-0959","type":"print"},{"value":"1525-139X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,20]]},"assertion":[{"value":"2019-03-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}